NEW - - - SKVI Now Trading Exclusively on OTCQB
Beginning February 22, 2011 Skinvisible (SKVI) will be quoted exclusively on the new OTCQB www.otcmarkets.com with an icon reading, "OTCQB -- U.S. Registered."
This new designation is used for OTC-traded companies that are U.S. registered and reporting. The OTCQB will help investors easily identify SEC reporting companies such as Skinvisible that are current with their disclosure obligations. As of February 18, 2011, market makers that previously traded Skinvisible on the OTCBB began exclusively trading Skinvisible on the new OTCQB. We do not believe it necessary at this time to reapply for quotation on the OTCBB because of the new trend in trading on the OTCQB.
To get a SKVI quote today, click here:
IMPORTANT: The OTCQB inter-dealer quotation system is interlinked with most financial websites but we encourage you to look at other sites if you do not see a current quote. All financial websites should be up-to-date in the near future.
Shares Outstanding Are: 111,269,969
Public Float: 55%
Insider Ownership: 45%
Fiscal Year End: December 31
October 19, 2014
Skinvisible's Subsidiary Kintari Announces Network Marketing Expert Dean Aldridge as Master Distributor
August 14, 2014
Skinvisible and Kintari Expands Team of Experts - Key Direct Sales and Production Staff Added
August 7, 2014
Skinvisible Announces Expansion with a New Scientific Skincare Company - Premium Invisicare Powered Kintari™ Products Go to Market
May 28, 2014
Skinvisible's Patent Portfolio Expands to Cover Cationic Actives
- Compositions with Imiquimod, Terbinafine, Miconazole Have Added Protection
May 16, 2014
Skinvisible's Patent Pending Hand Sanitizer Approval Extended for Ten Years
- Skinvisible Prepares to Obtain Authorization for DermSafe® Through-out Europe
March 25, 2014
Skinvisible's Sunscreen Meets New FDA Guidelines for Broad Spectrum and 80 Minute Water-Resistant Claims
- Plus Invisicare Patent Supports Eight Hours of Sunscreen Stabilization
CLICK HERE TO READ ALL NEWS RELEASES
In the News:
Skinvisible featured in Drug Development & Delivery journal
Skinvisible Shareholder Update: 2013 in Review
Sign up for Skinvisible Inc. Updates:
Click here to join our mailing list.